pharmacokinetics amikacin child pharmacokinetic variable amikacin measured 20 child adolescent four 16 year age mean plasma clearance amikacin 120 mlminute173 m2 major route elimination renal 82 simultaneously measured inulin clearance showed majority 64 drug filtered kidney excreted urine mean volume distribution amikacin 32 body weight halflife final pseudoequilibrium phase averaged 16 hour significant accumulation drug seen four dos given intravenously 420 mgm2 every 8 hour plasma concentration injection fourth dose averaged 24 plus minus 11 microgramml mean plasma concentration 60 75 minute injection drug 287 microgml little interpatient variation sd 35 microgml dose expressed term milligram per kilogram found child often needed 50 100 drug compared adult achieve equivalent plasma concentration larger requirement primarily due higher clearance amikacin proportion body weight dosage based surface area however resulted uniform requirement predictable plasma concentration patient studied